198HO02193 KALEIDO *PC

Print/PDF
Registration Name KAERGAARDEN HOTSPOT KALEIDO-ET
Registration Number HODNK003200304167
Primary NAAB Code 198HO02193
Secondary Code(s) 598HO02193
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 2/11/2019
aAa 231456
DMS -
GFI 11.6%
Genetic Codes * TL TV TY PC TC TD TM TR TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HHP-C
Sire WILDER HOTSPOT P-ET
MGS DE-SU 12109 BATTLECRY-ET
Beta Casein A2A2
Kappa Casein BB
Beta Lactoglobulin AA
INDEXES
NM$ 96, 83% R CM$ 119
NM Percentile 20% FM$ 46
GTPI 2711 GM$ 111
PRODUCTION TRAITS
2830 Dtrs 660 herds 0 % US 92% R
Milk 464 Fat, % -5 , -0.09%
SCS 2.8, 91% R Protein, % 27 , +0.04%
Feed Saved -114 , 53% R Milking Speed 7.37 , 64% R
Health & Fertility
Productive Life 1.4      88% R Mastitis 1.5      80% R
Heifer Livability 0.2       53% R Metritis 0.5      69% R
Livability -0.9      81% R D. Abom 0.0      72% R
DPR 1.4      90% R Ketosis 0.7      69% R
FSC 4.2      77% R R. Placenta -0.6      70% R
HCR 0.5      89% R Milk Fever 0.0      62% R
CCR 2.4      91% R
SCR -        -
DIA -0.3      39% R
RSP -0.2      47% R
Calving Traits
Sire CE 1.4      68% R 2291 Obs
Daughter CE 1.6      51% R 0 Obs, 1714 Dtrs
Sire SB 3.6      42% R 4038 Obs
Daughter SB 5.1      52% R 0 Obs, Dtrs
Gestation Length 0.5      77% R 0 Obs, 0 Dtrs
Early First Calving -0.1      75% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
0 Dtrs 0 herds 90% R
PTA Type 0.23 UDC 0.25
HCC 0.06 BWC 0.39
FLC -0.42
Linear Traits
Stature 1.34
Tall
Strength -0.09
Strong
Body Depth 0.12
Deep
Dairy Form -0.15
Closed
Rump Angle 1.82
Sloped
Thurl Width 0.39
Sloped
Rear Legs-Side View 0.39
Wide
Rear Legs-Rear View -0.32
H.-in
Foot Angle 0.21
Steep
Feet & Legs Score -0.04
Low
F.U. Attachment -0.72
Straight
Rear Udder Height 0.02
High
Rear Udder Width 0.37
Wide
Udder Cleft -0.33
Weak
Udder Depth -0.32
H.-in
Front Teat Placement -0.93
Wide
Rear Teat Placement -0.73
Wide
Teat Length 1.07
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO